Domtar declares regular quarterly dividend

Wed Feb 20, 2013 4:36pm EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130220:nPnMO878


TICKER SYMBOL

(NYSE: UFS) (TSX: UFS)


MONTREAL,  Feb. 20, 2013  /PRNewswire/ - Domtar Corporation today
 announced that its Board of Directors has approved its fourth quarterly
 dividend for the 2012 fiscal year on its common stock (NYSE: UFS) (TSX:
 UFS) and on Domtar (Canada) Paper Inc. (TSX: UFX) exchangeable shares.
 The dividend of  US$0.45  per share is payable on  April 15, 2013  to
 stockholders of record on  March 15, 2013.

About Domtar  

Domtar Corporation (NYSE: UFS) (TSX: UFS) designs, manufactures, markets
 and distributes a wide variety of fiber-based products including
 communication papers, specialty and packaging papers and adult
 incontinence products. The foundation of its business is a network of
 world class wood fiber converting assets that produce papergrade, fluff
 and specialty pulps. The majority of its pulp production is consumed
 internally to manufacture paper and consumer products. Domtar is the
 largest integrated marketer of uncoated freesheet paper in  North
 America  with recognized brands such as Cougar®, Lynx® Opaque Ultra, Husky® 
Opaque Offset, First Choice®  and Domtar EarthChoice®. Domtar is also a leading
marketer and producer of a complete line of
 incontinence care products marketed primarily under the Attends®  brand name.
Domtar owns and operates Ariva®, an extensive network of strategically located
paper and printing
 supplies distribution facilities. In 2012, Domtar had sales of  US$5.5
 billion  from nearly 50 countries. The Company employs approximately
 9,300 people. To learn more, visit  www.domtar.com.


SOURCE  DOMTAR CORPORATION

MEDIA AND INVESTOR RELATIONS

Pascal Bossé

Vice-President

Corporate Communications and Investor Relations

Tel.: 514-848-5938

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.